A Study of TXN10128 in Subjects With Solid Tumors

Clinical trial NCT05978492 · RECRUITING

Trial details

NCT number: NCT05978492
Sponsor: Txinno Bioscience Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Start date: 2023-07-27
Primary completion: 2025-12-31
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.